PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31953218 ↗2020Reported benefit

Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.

MouseEndotoxin/LPSMale

Model: Lipopolysaccharide-induced acute lung injury, with additional LPS-induced septic death and high-fat diet obesity models and cultured cardiomyocytes and macrophages

Arachidonic acid bound MD2, prevented saturated fatty acid and lipopolysaccharide-induced TLR4 activation, reduced proinflammatory cytokine induction and septic death in mice, and prevented MD2/TLR4 dimerisation, inflammatory factor induction and tissue injury in the acute lung injury and high-fat…

Extraction: extract · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.